Impact of Toll-like receptor 4 polymorphisms on risk of cancer
- PMID: 21081146
- DOI: 10.1016/j.humimm.2010.11.003
Impact of Toll-like receptor 4 polymorphisms on risk of cancer
Abstract
Toll-like receptor 4 (TLR4) is one of the key immune system effectors playing the main role in recognition of viruses and bacteria. Dysregulation of the TLR4 signaling owing to single nucleotide polymorphisms (SNPs) may alter the ligand binding and balance between pro- and anti-inflammatory cytokines, thereby modulating the risk of chronic inflammation and cancer. TLR4 polymorphisms may be associated with at least nine types of cancer. The most intensively investigating TLR4 polymorphisms are Asp299Gly (rs4986790) and Thr399Ile (rs4986791). It seems to be that Asp299Gly and Thr399Ile are related to increased risk of precancerous gastric lesions, and, possibly, gastric cancer. Thr399Ile also may be connected with gallbladder cancer, and both of these polymorphisms apparently have no impact on risk of prostate cancer. However, the data about many SNPs and their associations with different types of cancer are conflicting, and further large, well-designed, comprehensive studies in various populations are necessary for solution of this problem. The short list of TLR4 SNPs for further investigation may include TLR4_896A/G (Asp299Gly, rs4986790), TLR4_1196C/T (Thr399Ile, rs4986791), Thr135Ala, TLR4_1859 G/A (rs11536858), TLR4_2032T/C (rs10116253), TLR4_2437A/G (rs1927914), TLR4_2856T/C (rs10759932), TLR4_3725 G/C (rs11536889), TLR4_7764 G/A (rs1927911), TLR4_11350G/C, TLR4_11912 G/T (rs2149356), TLR4_16649G/C (rs7873784), and TLR4_17050T/C (rs11536891).
Copyright © 2011 IBRO. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer.BMC Cancer. 2007 Apr 26;7:70. doi: 10.1186/1471-2407-7-70. BMC Cancer. 2007. PMID: 17462092 Free PMC article.
-
Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection.Eur Cytokine Netw. 2006 Mar;17(1):29-34. Eur Cytokine Netw. 2006. PMID: 16613760
-
LPS-mediated production of pro/anti-inflammatory cytokines and eicosanoids in whole blood samples: biological effects of +896A/G TLR4 polymorphism in a Sicilian population of healthy subjects.Mech Ageing Dev. 2011 Mar;132(3):86-92. doi: 10.1016/j.mad.2010.12.005. Epub 2011 Jan 14. Mech Ageing Dev. 2011. PMID: 21238472
-
Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.PLoS One. 2014 Oct 31;9(10):e110569. doi: 10.1371/journal.pone.0110569. eCollection 2014. PLoS One. 2014. PMID: 25360682 Free PMC article. Review.
-
Polymorphisms in Toll-like receptor genes and risk of cancer.Oncogene. 2008 Jan 7;27(2):244-52. doi: 10.1038/sj.onc.1210912. Oncogene. 2008. PMID: 18176606 Review.
Cited by
-
Gene polymorphisms: the keys for marker assisted selection and unraveling core regulatory pathways for mastitis resistance.J Mammary Gland Biol Neoplasia. 2011 Dec;16(4):421-32. doi: 10.1007/s10911-011-9238-9. Epub 2011 Oct 14. J Mammary Gland Biol Neoplasia. 2011. PMID: 21997401 Review.
-
Toll-Like Receptor 4 Wild Type Homozygozity of Polymorphisms +896 and +1196 Is Associated with High Gastrin Serum Levels and Peptic Ulcer Risk.PLoS One. 2015 Jul 10;10(7):e0131553. doi: 10.1371/journal.pone.0131553. eCollection 2015. PLoS One. 2015. PMID: 26161647 Free PMC article.
-
The Yin and Yang of Toll-like receptors in cancer.Oncogene. 2014 Jul 3;33(27):3485-95. doi: 10.1038/onc.2013.302. Epub 2013 Aug 12. Oncogene. 2014. PMID: 23934186 Free PMC article. Review.
-
Role of TLR4 rs4986790A>G and rs4986791C>T Polymorphisms in the Risk of Inflammatory Bowel Disease.Gastroenterol Res Pract. 2015;2015:141070. doi: 10.1155/2015/141070. Epub 2015 May 18. Gastroenterol Res Pract. 2015. PMID: 26089865 Free PMC article. Review.
-
Linking dysbiosis to precancerous stomach through inflammation: Deeper than and beyond imaging.Front Immunol. 2023 Mar 31;14:1134785. doi: 10.3389/fimmu.2023.1134785. eCollection 2023. Front Immunol. 2023. PMID: 37063848 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
